Understanding Laboratory Corp’s Unusual Options Activity
On Friday, shares of Laboratory Corp (NYSE:LH) saw unusual options activity. After the option alert, the stock price moved down to $299.39.
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
Analyzing Laboratory Corp’s Unusual Options Activity
Shares of Laboratory Corp (NYSE:LH) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $301.61.
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 154 companies achieved new highs for the year.
Mizuho Maintains Buy on Laboratory Corp, Raises Price Target to $318
Mizuho analyst Ann Hynes maintains Laboratory Corp (NYSE:LH) with a Buy and raises the price target from $310 to $318.
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs.
Earnings Scheduled For July 29, 2021
Companies Reporting Before The Bell
• Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
The Daily Biotech Pulse: Priority Review For Amgen’s Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)
The Daily Biotech Pulse: Iterum’s Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)